cardiomet obesity1: Lancet Commission Releases Milestone Definition & Diagnostic Criteria of Clinical Obesity
Chronic Inflammatory Demyelinating Polyneuropathy (CIDP): Pathophysiology, Diagnosis, and New and Emerging Treatment Options
FcRn Inhibition for the Treatment of Generalized Myasthenia Gravis (gMG): Patient Selection, Tailoring Dosing Regimens, Updated Disease Management Paradigms
Best Practices for Implementing Dual Endothelin Angiotensin Receptor Antagonist Therapeutics in Patients with IgAN – Module III